NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
Moore Kuehn is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- Amedisys, Inc. (NASDAQ: AMED)
Amedisys has agreed to merge with Optum. Under the proposed transaction, Amedisys shareholders will receive $101.00 in cash per share.
- Decibel Therapeutics, Inc. (NASDAQ: DBTX)
Decibel Therapeutics has agreed to merge with Regeneron Pharmaceuticals. Under the proposed transaction, Decibel shareholders will receive $4.00 in cash and a non-tradeable contingent value right to receive up to $3.50 per share.
- Reata Pharmaceuticals, Inc. (NASDAQ: RETA)
Reata Pharmaceuticals has agreed to merge with Biogen. Under the proposed transaction, Reata shareholders will receive $172.50 in cash per share.
- Surface Oncology, Inc. (NASDAQ: SURF)
Surface Oncology has agreed to merge with Coherus BioSciences. Under the proposed transaction, Surface Oncology shareholders will receive $5.28 in cash per share.
Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245
